Vir Biotechnology Inc (VIR)

R&D Expense Growth

22.76%

Quarterly · Period ending:

VIR logo

VIR R&D Expense Growth

Latest reported22.76%
VIR Quarterly R&D Growth (QoQ) (0.00% → 22.76%)
High-resolution chart · PNG

VIR r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vir Biotechnology Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
22.7568%
25.102%
-42.1717%
74.8038%
-26.2628%
40.5244%
-56.9574%
93.8547%
4.155%
4.9399%
-37.6781%
-14.0295%
29.1388%
-15.543%
36.2149%
-0.8829%
27.9797%
-30.0781%
31.3339%
12.9484%
-35.9449%
55.6369%
25.279%
-11.5801%
35.4462%
18.8147%
25.9715%
33.0639%
15.568%
17.8316%
-27.6544%
20.3288%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.